TY - JOUR
T1 - Assessment of serum total 25-hydroxyvitamin D assay commutability of Standard Reference Materials and College of American Pathologists Accuracy-Based Vitamin D (ABVD) Scheme and Vitamin D External Quality Assessment Scheme (DEQAS) materials
T2 - Vitamin D Standardization Program (VDSP) Commutability Study 2
AU - Camara, Johanna E.
AU - Wise, Stephen A.
AU - Hoofnagle, Andrew N.
AU - Williams, Emma L.
AU - Carter, Graham D.
AU - Jones, Julia
AU - Burdette, Carolyn Q.
AU - Hahm, Grace
AU - Nalin, Federica
AU - Kuszak, Adam J.
AU - Merkel, Joyce
AU - Durazo-Arvizu, Ramón A.
AU - Lukas, Pierre
AU - Cavalier, Étienne
AU - Popp, Christian
AU - Beckert, Christian
AU - Schultess, Jan
AU - Van Slooten, Glen
AU - Tourneur, Carole
AU - Pease, Camille
AU - Kaul, Ravi
AU - Villarreal, Alfredo
AU - Ivison, Fiona
AU - Fischer, Ralf
AU - van den Ouweland, Jody M.W.
AU - Ho, Chung S.
AU - Law, Emmett W.K.
AU - Simard, Jean Nicolas
AU - Gonthier, Renaud
AU - Holmquist, Brett
AU - Batista, Marcelo Cidade
AU - Pham, Heather
AU - Bennett, Alex
AU - Meadows, Sarah
AU - Cox, Lorna
AU - Jansen, Eugene
AU - Khan, Dilshad Ahmed
AU - Robyak, Kimberly
AU - Creer, Michael H.
AU - Kilbane, Mark
AU - Twomey, Patrick J.
AU - Freeman, James
AU - Parker, Neil
AU - Yuan, Jinyun
AU - Fitzgerald, Robert
AU - Mushtaq, Sohail
AU - Clarke, Michael W.
AU - Breen, Norma
AU - Simpson, Christine
AU - Sempos, Christopher T.
N1 - Publisher Copyright:
© 2021, This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.
PY - 2021/8
Y1 - 2021/8
N2 - An interlaboratory study was conducted through the Vitamin D Standardization Program (VDSP) to assess commutability of Standard Reference Materials® (SRMs) and proficiency testing/external quality assessment (PT/EQA) samples for determination of serum total 25-hydroxyvitamin D [25(OH)D] using ligand binding assays and liquid chromatography-tandem mass spectrometry (LC-MS/MS). A set of 50 single-donor serum samples were assigned target values for 25-hydroxyvitamin D2 [25(OH)D2] and 25-hydroxyvitamin D3 [25(OH)D3] using reference measurement procedures (RMPs). SRM and PT/EQA samples evaluated included SRM 972a (four levels), SRM 2973, six College of American Pathologists (CAP) Accuracy-Based Vitamin D (ABVD) samples, and nine Vitamin D External Quality Assessment Scheme (DEQAS) samples. Results were received from 28 different laboratories using 20 ligand binding assays and 14 LC-MS/MS methods. Using the test assay results for total serum 25(OH)D (i.e., the sum of 25(OH)D2 and 25(OH)D3) determined for the single-donor samples and the RMP target values, the linear regression and 95% prediction intervals (PIs) were calculated. Using a subset of 42 samples that had concentrations of 25(OH)D2 below 30 nmol/L, one or more of the SRM and PT/EQA samples with high concentrations of 25(OH)D2 were deemed non-commutable using 5 of 11 unique ligand binding assays. SRM 972a (level 4), which has high exogenous concentration of 3-epi-25(OH)D3, was deemed non-commutable for 50% of the LC-MS/MS assays. Graphical abstract: [Figure not available: see fulltext.]
AB - An interlaboratory study was conducted through the Vitamin D Standardization Program (VDSP) to assess commutability of Standard Reference Materials® (SRMs) and proficiency testing/external quality assessment (PT/EQA) samples for determination of serum total 25-hydroxyvitamin D [25(OH)D] using ligand binding assays and liquid chromatography-tandem mass spectrometry (LC-MS/MS). A set of 50 single-donor serum samples were assigned target values for 25-hydroxyvitamin D2 [25(OH)D2] and 25-hydroxyvitamin D3 [25(OH)D3] using reference measurement procedures (RMPs). SRM and PT/EQA samples evaluated included SRM 972a (four levels), SRM 2973, six College of American Pathologists (CAP) Accuracy-Based Vitamin D (ABVD) samples, and nine Vitamin D External Quality Assessment Scheme (DEQAS) samples. Results were received from 28 different laboratories using 20 ligand binding assays and 14 LC-MS/MS methods. Using the test assay results for total serum 25(OH)D (i.e., the sum of 25(OH)D2 and 25(OH)D3) determined for the single-donor samples and the RMP target values, the linear regression and 95% prediction intervals (PIs) were calculated. Using a subset of 42 samples that had concentrations of 25(OH)D2 below 30 nmol/L, one or more of the SRM and PT/EQA samples with high concentrations of 25(OH)D2 were deemed non-commutable using 5 of 11 unique ligand binding assays. SRM 972a (level 4), which has high exogenous concentration of 3-epi-25(OH)D3, was deemed non-commutable for 50% of the LC-MS/MS assays. Graphical abstract: [Figure not available: see fulltext.]
UR - http://www.scopus.com/inward/record.url?scp=85106917471&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85106917471&partnerID=8YFLogxK
U2 - 10.1007/s00216-021-03470-w
DO - 10.1007/s00216-021-03470-w
M3 - Article
C2 - 34184102
AN - SCOPUS:85106917471
SN - 1618-2642
VL - 413
SP - 5067
EP - 5084
JO - Analytical and Bioanalytical Chemistry
JF - Analytical and Bioanalytical Chemistry
IS - 20
ER -